Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension  Tyrus Stewart, Flavia F. Jung, Jennifer Manning,

Slides:



Advertisements
Similar presentations
Nina Vasavada, Rajiv Agarwal  Kidney International 
Advertisements

Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function  N. Rabbani, K. Sebekova, K. Sebekova, A.
Volume 69, Issue 5, Pages (March 2006)
Volume 63, Issue 1, Pages (January 2003)
M.S. Mozaffari, C. Patel, R. Abdelsayed, S.W. Schaffer 
Plasma sodium and hypertension
Membranous nephropathy: When and how to treat
Volume 61, Issue 3, Pages (March 2002)
Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan 
Mycophenolate mofetil treatment for primary glomerular diseases
Glomerulus number and blood pressure in the Prague hypertensive rat
Volume 68, Issue 5, Pages (November 2005)
Volume 63, Issue 4, Pages (April 2003)
Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil  Q. Sun, Z-H. Liu, Z. Cheng, J. Chen,
Volume 73, Issue 5, Pages (March 2008)
The myogenic response in uremic hypertension
Volume 68, Issue 3, Pages (September 2005)
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
Nosratola D. Vaziri, Kaihui Liang, Yaoxian Ding  Kidney International 
Endothelial-derived vasoactive mediators in polycystic kidney disease
Volume 56, Issue 4, Pages (October 1999)
Prenatal programming of adult hypertension in the rat
Volume 60, Issue 2, Pages (August 2001)
Volume 82, Issue 3, Pages (August 2012)
Lori L. Woods, Douglas A. Weeks, Ruth Rasch  Kidney International 
Volume 81, Issue 3, Pages (February 2012)
Volume 67, Issue 3, Pages (March 2005)
Volume 62, Issue 3, Pages (September 2002)
The epidemiology of chronic kidney disease
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
R. Agarwal, A.R. Rizkala, M.O. Kaskas, R. Minasian, J.R. Trout 
Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function  N. Rabbani, K. Sebekova, K. Sebekova, A.
Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: Reversal by lifelong antioxidant supplementation  Chang-de Zhan, Ram K. Sindhu, Nosratola.
Volume 68, Issue 6, Pages (December 2005)
Blood pressure targets in hemodialysis patients
Volume 64, Issue 1, Pages (July 2003)
Volume 72, Issue 12, Pages (December 2007)
Volume 68, Issue 2, Pages (August 2005)
Volume 85, Issue 3, Pages (March 2014)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 62, Issue 3, Pages (September 2002)
Proteinuria and hypertensive nephrosclerosis in African Americans
Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension  Zhenmin Ni, Shahrooz Bemanian, Salah D. Kivlighn,
Volume 74, Issue 8, Pages (October 2008)
Volume 63, Issue 3, Pages (March 2003)
Volume 69, Issue 10, Pages (May 2006)
Volume 81, Issue 8, Pages (April 2012)
Volume 58, Issue 3, Pages (September 2000)
Volume 63, Issue 1, Pages (January 2003)
Nina Vasavada, Chandan Saha, Rajiv Agarwal  Kidney International 
A man with a hole in his penis
An unusual presentation of hematuria
Volume 82, Issue 9, Pages (November 2012)
Nosratola D. Vaziri, Fariba Oveisi, Yaoxian Ding  Kidney International 
The course of the remnant kidney model in mice
Organ transplantation goes to the movies
Nina Vasavada, Rajiv Agarwal  Kidney International 
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
Volume 75, Issue 12, Pages (June 2009)
Salt sensitivity in genetically hypertensive rats of the Lyon strain
Is it the low-protein diet or simply the salt restriction?
Volume 70, Issue 3, Pages (August 2006)
Role of immunocompetent cells in nonimmune renal diseases
MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis  Antonio Guasch, M.D., Carlos F. Zayas, Kamal.
Volume 62, Issue 5, (November 2002)
Effect of prenatal dexamethasone on rat renal development
Volume 61, Issue 1, Pages (January 2002)
Graft flow as a predictor of thrombosis in hemodialysis grafts
Quantitative estimation of renal blood flow by power Doppler ultrasonography in renovascular hypertensive dogs  Tetsumasa Miyajima, Hiroshi Yokoyama,
Presentation transcript:

Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension  Tyrus Stewart, Flavia F. Jung, Jennifer Manning, V. Matti Vehaskari  Kidney International  Volume 68, Issue 5, Pages 2180-2188 (November 2005) DOI: 10.1111/j.1523-1755.2005.00674.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Tissue nitrotyrosine content. Kidneys from newborn (A) and 4-week-old (B) offspring from control (C) and low-protein (LP) pregnancies (N = 8 in each group). Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 CD3-positive cell count. Kidneys from 4-week-old offspring from control (C) and low-protein (LP) pregnancies (N = 4 in each group). Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Urine NOx (nitrite + nitrate) excretion. Kidneys in 4-week-old (A) and 8-week-old (B) offspring from control (C) and low-protein (LP) pregnancies (N = 8 in each 4-week-old group) (N = 16 and 20 in 8-week-old control and LP groups, respectively). Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 CD3 (A) and ED1 (B) positive cell count. Kidneys from 8-week-old offspring from control (C) and low-protein (LP) pregnancies treated with mycophenolate mofetil (MMF) or vehicle (V) from age 3 to 6 weeks (N = 4 in each group). ***P < 0.001 compared with control-vehicle group; +++P < 0.001 compared with low protein diet-vehicle group. Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Tissue nitrotyrosine content. Kidneys from 8-week-old offspring from control (C) and low-protein (LP) pregnancies treated with mycophenolate mofetil (MMF) or vehicle (V) from age 3 to 6 weeks (N = 8 in each group). *P < 0.05 compared with control-vehicle group; +++P < 0.001 compared with low protein diet-vehicle group. Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Urine NOx (nitrite + nitrate) excretion. Kidneys in 8-week-old offspring from control (C) and low-protein (LP) pregnancies treated with mycophenolate mofetil (MMF) or vehicle (V) from age 3 to 6 weeks (N = 6 in control-vehicle group) (N = 11 in control-MMF group) (N = 9 in low protein diet-vehicle group) (N = 8 in low protein diet-MMF group). P = 0.026 by analysis of variance (ANOVA) (no significant differences in Tukey's post test). Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Systolic blood pressure. Offspring from control (open circles and squares) and low-protein (LP) (solid circles and squares) pregnancies treated with vehicle (dashed lines) or mycophenolate mofetil (solid lines) (N = 11-16 in each group). **P < 0.01 against all other groups. Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 CD3 positive cell count. Kidneys from 8-week-old untreated offspring from control (C) and low-protein (LP) pregnancies and from 8-week-old low protein diet offspring treated with Tempol (LP-T) from age 3 to 6 weeks (N = 4 in each group). ***P < 0.001 compared with control group; +++P < 0.001 compared with low protein diet group. Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Tissue nitrotyrosine content. Kidneys from 8-week-old untreated offspring from control (C) and low-protein (LP) pregnancies and from 8-week-old low protein diet offspring treated with Tempol (LP-T) from age 3 to 6 weeks (N = 8 in each group). *P < 0.05 compared with control group; +++P < 0.001 compared with low protein diet group. Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 10 Urine NOx (nitrite + nitrate) excretion. Kidneys in 8-week-old offspring from untreated control (C) and low-protein (LP) pregnancies and from offspring treated with Tempol (LP-T) from age 3 to 6 weeks (N = 9 in control group) (N = 10 in low protein diet group) (N = 10 in low protein diet-Tempol group). P = 0.48 by analysis of variance (ANOVA). Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 11 Systolic blood pressure. Offspring from control (open circles and solid line) and untreated low protein (solid circles and solid line) pregnancies and of low protein diet offspring treated with Tempol (solid squares and dashed line) from age 3 to 6 weeks (N = 14 to 19 in each group). ***P < 0.0001 vs. all other groups. Kidney International 2005 68, 2180-2188DOI: (10.1111/j.1523-1755.2005.00674.x) Copyright © 2005 International Society of Nephrology Terms and Conditions